Sören Mellstig, Chairman, *1951. 
Elected 2016. Chairman since 2016.

MBA
Chairman of Trelleborg AB (publ), Impilo AB and Ellevio AB. Previous management positions at Akzo Nobel, and served as CFO and Vice President of Incentive, CFO, President and finally President and CEO of Gambro 2000-2006.

Independent of company and major shareholders.
CellaVision Shares: 42. 944


Christer Fåhraeus, *1965.
Founder. Board member since 1994.

M.Sc. Bioengineering, B.Sc. Mathematics, Ph.D. (hc) Lund University.
CEO of EQL Pharma AB. Former positions include CEO of Anoto Group AB and Agellis Group AB. Founder of Anoto Group AB, Precise Biometrics AB and Agellis Group AB among others.
Chairman of the Board of Longboat laboratories AB, Respiratorius AB and Flatfrog Laboratories AB. Member of the Board of EQL Pharma AB, Lunds Universitets Innovationssystem AB, Fårö Capital AB and Reccan AB.

Dependent of major shareholders.
CellaVision Shares: 2.316.000


Jurgen Riedl, *1977.  
Elected 2018.

Post Doc and PhD
Strong background in clinical laboratory work and is an internationally recognized expert in hematology. Many years experience from several senior positions at Albert Schweitzer Hospital in Dordrecht, Beatrix Hospital in Gorinchem and Ikazia Hospital in Rotterdam in Clinical Chemistry and Hematology. 

Independent of company and major shareholders.
CellaVision Shares: -


Torbjörn Kronander, * 1957.
Elected 2007.

Doctor of Technology, MBA.
President of Sectra AB and Sectra Medical AB. Founder of Sectras’ medical division and co-founder of the research center CMIV(Center for Medical Image science and Visualization) in Linköping.
Chairman of the Board of Sectra Sverige AB and Sectra Mamea AB. Member of the Board of Sectra AB and Shannon AB.

Independent of company and major shareholders.
CellaVision Shares: 278.000


Anna Malm Bernsten, * 1961
Elected 2010.

M.Sc. Chemical Engineering.
CEO of Bernsten Konsult AB. Former positions include CEO and President of Carmeda AB and management positions at Pharmacia & Upjohn and GE Healthcare Life Sciences and Chairman of the Board at  Oatly AB. Present Chairman of the Board at Björn Axén Institute AB and Medivir AB. Member og the Board at Pågengruppen.

Independent of company and major shareholders.
CellaVision Shares: –


Niklas Prager, * 1970
Elected 2014.

MBA
Advisor and consultant for a number of life-science companies. Former positions include CEO of Medivir AB, Envirotainer AB, Qbtech AB and for Pfizer Sweden. Member of the Board of Qbtech AB and Adero AB.

Independent of company and major shareholders.
CellaVision Shares: 8.720


Åsa Hedin, * 1968
Elected 2015.

McS Biophysics
Former positions include senior positions at Elekta AB with responsibility for strategy, marketing, training and management positions at Siemens Healthcare and Gambro. Member of the Board at Nolato AB, Immuniova AB, Fingerprint AB and Tobii AB.

Independent of company and major shareholders.
CellaVision Shares: -


Stefan Wolf, * 1964
Elected 2018.

Divisional President of the Immune Diagnostic Division (IDD), at Thermo Fisher Scientific and has been a member of the European Diagnostic Manufacturers Association (EDMA) Board for many years. Furthermore, Stefan has previously held the position as CEO at of Hemostasis, Hematology, Specialties (HHS), Siemens Healthcare Diagnostics/Siemens Healthineers.

Independent of company and major shareholders.
CellaVision Shares: -

Access our Student Resources

To access this resource, please provide the following information about yourself.